Kindling Bio
Founded 2025 · 2 employees on LinkedIn · 1 known investors
Kindling Bio develops targeted cancer gene therapy for children that uses the immune system to fight a range of tumors. The company focuses on pediatric oncology, aiming to replace toxic adult-designed therapies with treatments tailored to children's biology.
Investors · 1
Frequently asked questions
- What does Kindling Bio do?
- Kindling Bio develops targeted cancer gene therapy for children that uses the immune system to fight a range of tumors. The company focuses on pediatric oncology, aiming to replace toxic adult-designed therapies with treatments tailored to children's biology.
- Who are Kindling Bio's investors?
- Kindling Bio's investors include Deep Science Ventures.